ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,295Medicare Part D Prescriptions Filled, Including Refills

Rank: 113 out of 2588

$774K Total Retail Price of All Prescriptions

Rank: 176 out of 2588

464 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
40% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 464 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

23% of this provider’s 464 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

3% of this provider’s 13,133 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
SIMVASTATIN 597 480 1 1
FUROSEMIDE 573 529 2 5
LEVOTHYROXINE SODIUM 552 496 3 2
OMEPRAZOLE 530 463 4 6
HYDROCODONE-ACETAMINOPHEN 526 303 S3 5 7
LISINOPRIL 445 316 6 3
AMLODIPINE BESYLATE 425 339 7 4
POTASSIUM CHLORIDE 379 345 8 15
METOPROLOL SUCCINATE 366 338 9 12
WARFARIN SODIUM 358 344 10 10
METOPROLOL TARTRATE 300 205 11 9
GABAPENTIN 294 217 12 18
FENOFIBRATE 288 267 13 64
METFORMIN HCL 278 224 14 8
TRIAMTERENE-HCTZ 274 228 15 46
TRAMADOL HCL 256 181 16 19
ATENOLOL 233 205 17 14
CARVEDILOL 219 193 18 20
HYDROCHLOROTHIAZIDE 208 168 19 13
NEXIUM 198 135 20 41
PANTOPRAZOLE SODIUM 197 167 21 28
ALENDRONATE SODIUM 191 191 22 21
MELOXICAM 177 158 23 51
CITALOPRAM HBR 169 125 24 27
LOSARTAN POTASSIUM 165 147 25 17
PROAIR HFA 158 93 26 50
CLOPIDOGREL 149 137 27 30
GLYBURIDE 148 138 R 28 65
GLIPIZIDE 122 61 29 44
LISINOPRIL-HYDROCHLOROTHIAZIDE 119 89 30 35
AMITRIPTYLINE HCL 113 74 R 31 91
DONEPEZIL HCL 113 113 31 22
LANTUS 111 79 33 47
TAMSULOSIN HCL 111 108 33 23
PRAVASTATIN SODIUM 111 88 33 16
DIGOXIN 108 103 36 38
LOVASTATIN 108 81 36 34
DIOVAN 106 103 38 29
RANITIDINE HCL 105 84 39 37
ATORVASTATIN CALCIUM 102 93 40 11
CARBIDOPA-LEVODOPA 100 100 41 83
NAMENDA 89 89 42 32
SPIRONOLACTONE 88 88 43 58
PLAVIX 87 73 44 43
KLOR-CON M20 86 60 45 52
SINGULAIR 86 57 45 94
TRAZODONE HCL 85 62 47 61
HYDRALAZINE HCL 85 70 47 53
LEVOFLOXACIN 84 63 49 77
KLOR-CON 10 83 70 50 75
FLUOXETINE HCL 80 67 51 92
AZITHROMYCIN 80 67 51 45
ZOLPIDEM TARTRATE 70 38 53 24
PREDNISONE 68 62 54 42
SERTRALINE HCL 66 47 55 26
ADVAIR DISKUS 64 35 56 48
CEFUROXIME 60 51 57 183
PAROXETINE HCL 60 24 57 71
CLONIDINE HCL 60 42 57 54
PRAMIPEXOLE DIHYDROCHLORIDE 60 50 57 188
AMOX TR-POTASSIUM CLAVULANATE 60 48 57 131
POLYETHYLENE GLYCOL 3350 59 52 62 55
ENALAPRIL MALEATE 58 56 63 31
MONTELUKAST SODIUM 58 30 63 153
METHADONE HCL 57 12 S2 65 305
PROPRANOLOL HCL 57 39 65 128
CRESTOR 56 51 67 25
DOXYCYCLINE HYCLATE 55 51 68 151
OXYBUTYNIN CHLORIDE ER 55 55 68 85
FLUTICASONE PROPIONATE 54 18 70 40
ALLOPURINOL 54 41 70 33
CLOTRIMAZOLE-BETAMETHASONE 53 46 72 155
CIPROFLOXACIN HCL 53 44 72 82
GLIPIZIDE ER 53 52 72 73
DILTIAZEM 24HR ER 53 44 72 166
VENTOLIN HFA 53 0 72 101
BUSPIRONE HCL 51 42 77 173
EVISTA 51 41 77 178
LOSARTAN-HYDROCHLOROTHIAZIDE 50 47 79 66
VESICARE 50 39 79 172
TRICOR 50 42 79 122
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.